Renaissance Capital logo

RGNT News

Israeli hydrogel implant developer Regentis Biomaterials prices US IPO at $8, below the range

Regentis Biomaterials logo

Regentis Biomaterials, an Israeli regenerative medicine company developing orthopedic hydrogel implants, raised $10 million by offering 1.3 million shares at $8, below the range of $10 to $12. The company offered 0.3 million more shares than anticipated. At...read more

US IPO Week Ahead: Quiet holiday week set to close out November

MDLN

There is currently one small IPO currently scheduled in the week ahead, although some small deals may join the calendar at the last minute. New IPO filings could come online, as the SEC continues to work through a backlog of applications received during the...read more

US IPO Week Ahead: Missouri bank and Christian tech platform lead first week post-shutdown

CBC

Now that the longest government shutdown in history has concluded, the SEC is poised to resume regular operations. Three deals are on the calendar for the week ahead. OTC-listed bank Central Bancompany (CBC) plans to raise $400 million at a $5.4 billion...read more

US IPO Weekly Recap: One micro-cap lists, while Klarna and Hinge Health’s IPO filings boosts pipeline

MWYN

Only one IPO listed this week. Five IPOs and five SPACs submitted initial filings. Home improvement products distributor Marwynn (MWYN) priced its IPO at the bottom of the range to raise $8 million at a $68 million market cap. Operating through its...read more